On October 16, 2019, Shenzhen MGI Technology Co., Ltd. won Award of Biotechnology Innovation Enterprise of the Guangdong, Hong Kong and Macau Greater Bay Area. The event was hosted by China Venture Industry Research Institute and KPMG China, and was hosted by Guangdong Medical Valley. The Greater Bay Biotechnology Innovation and Development Summit was also held on the same day.

In addition, the event site also released the "Top 50 Innovation Reports of Biotech Enterprises in Guangdong, Hong Kong and Macau" based on the top 50, showing the latest progress and achievements of biotechnology innovation enterprises in Greater Bay AreaDistrict of Guangdong, Hong Kong and Macao, and analyzing the latest developments. Trends, jointly interpreting the development and innovation opportunities in the Greater Bay Area.

For example, the biomedical industry gathers and develops, and services tend to be large-scale; regional synergy and differentiated development are the inevitable trend of industrial development; 5g technology helps to form a large-scale medical IoT ecosystem; artificial intelligence and biomedicine continue to merge and deepen.

In this context, MGI is committed to leading the industry's development trend, providing users with a complete range of gene sequencing equipment to adapt to a variety of application scenarios to meet the diverse needs of customers.

Recently, MGI has just delivered the world's most powerful gene sequencing instrument, DNBSEQ-7, Twhich is called "Super Life Computer", which can help China's gene sequencing industry to further break the technical barriers of overseas companies, in sequencing equipment technology and A comprehensive lead in cost-effectiveness and an important force driving the development of the global genetic industry.